These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Biochemical investigation of the basis for the genetic N-acetylation polymorphism in the inbred hamster. Hein DW; Kirlin WG; Ferguson RJ; Weber WW J Pharmacol Exp Ther; 1985 Aug; 234(2):358-64. PubMed ID: 3874952 [TBL] [Abstract][Full Text] [Related]
8. N-acetylation pharmacogenetics. Michaelis-Menten constants for arylamine drugs as predictors of their N-acetylation rates in vivo. Andres HH; Weber WW Drug Metab Dispos; 1986; 14(4):382-5. PubMed ID: 2873982 [TBL] [Abstract][Full Text] [Related]
9. Antinuclear antibodies related to acetylator phenotype in mice. Tannen RH; Weber WW J Pharmacol Exp Ther; 1980 Jun; 213(3):485-90. PubMed ID: 6970809 [TBL] [Abstract][Full Text] [Related]
10. Distribution of 2-aminofluorene and p-aminobenzoic acid N-acetyltransferase activity in tissues of C57BL/6J rapid and B6.A-NatS slow acetylator congenic mice. Chung JG; Levy GN; Weber WW Drug Metab Dispos; 1993; 21(6):1057-63. PubMed ID: 7905384 [TBL] [Abstract][Full Text] [Related]
11. Extrahepatic expression of N-acetylator genotype in the inbred hamster. Hein DW; Kirlin WG; Ogolla F; Trinidad A Drug Metab Dispos; 1987; 15(1):68-73. PubMed ID: 2881761 [TBL] [Abstract][Full Text] [Related]
12. Immunological evidence for N-acetyltransferase isozymes in the rabbit. Reeves PT; Kinnear BF; Minchin RF; Ilett KF Mol Pharmacol; 1991 Jan; 39(1):42-8. PubMed ID: 1987451 [TBL] [Abstract][Full Text] [Related]
13. Rodent models of the human isoniazid-acetylator polymorphism. Tannen RH; Weber WW Drug Metab Dispos; 1979; 7(5):274-9. PubMed ID: 40765 [TBL] [Abstract][Full Text] [Related]
14. The N-acetylation of sulfamethazine and p-aminobenzoic acid by human liver slices in dynamic organ culture. Gunawardhana L; Barr J; Weir AJ; Brendel K; Sipes IG Drug Metab Dispos; 1991; 19(3):648-54. PubMed ID: 1680632 [TBL] [Abstract][Full Text] [Related]
15. N-Acetylation of drugs. A genetically controlled reciprocal relationship between drug N-acetylating enzymes of rabbit liver and peripheral blood cells. Szabadi RR; McQueen CA; Drummond GS; Weber WW Drug Metab Dispos; 1978; 6(1):16-20. PubMed ID: 23269 [TBL] [Abstract][Full Text] [Related]
16. N-acetylation of drugs. Pharmacogenetic studies in rabbits selected for their acetylator characteristics. Weber WW; Miceli JN; Hearse DJ; Drummond GS Drug Metab Dispos; 1976; 4(1):94-101. PubMed ID: 3408 [TBL] [Abstract][Full Text] [Related]
17. Slow acetylation in mice is caused by a labile and catalytically impaired mutant N-acetyltransferase (NAT2 9). De Leon JH; Martell KJ; Vatsis KP; Weber WW Drug Metab Dispos; 1995 Dec; 23(12):1354-61. PubMed ID: 8689943 [TBL] [Abstract][Full Text] [Related]
18. A unique pharmacogenetic expression of the N-acetylation polymorphism in the inbred hamster. Hein DW; Omichinski JG; Brewer JA; Weber WW J Pharmacol Exp Ther; 1982 Jan; 220(1):8-15. PubMed ID: 7053425 [TBL] [Abstract][Full Text] [Related]
19. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus. Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184 [TBL] [Abstract][Full Text] [Related]
20. Relationship between in vivo acetylator phenotypes and cytosolic N-acetyltransferase and O-acetyltransferase activities in human uroepithelial cells. Frederickson SM; Messing EM; Reznikoff CA; Swaminathan S Cancer Epidemiol Biomarkers Prev; 1994; 3(1):25-32. PubMed ID: 8118381 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]